2018 Annual Meeting | C33 - Clinicopathological Correlation Session in Dementia

Date Sunday 04/22/18

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) David Irwin, MD

Topic(s)

Learning Objectives Participants should be able to obtain familiarity with main neuropathological diagnoses underlying dementia, gain in-depth knowledge of clinical-pathological associations in dementia syndromes, and understand the principles of interpretation of molecular imaging results based on clinicopathological associations in dementia.

CME Available 2.00 CME credits

Core Competencies Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
07:00 AM - 07:15 AM	Luncheon	Introduction David Irwin, MD
07:15 AM - 07:35 AM	Speaker	Primary Progressive Aphasia M. M. Mesulam, MD, FAAN
07:35 AM - 07:55 AM	Speaker	Lewy Body Disorders James B. Leverenz, MD, FAAN
07:55 AM - 08:15 AM	Speaker	Alzheimer's Disease and Aging
08:15 AM - 09:00 AM	Speaker	Interactive Case Presentations , David Irwin, MD, James B. Leverenz, MD, FAAN, M. M. Mesulam, MD, FAAN

Faculty Disclosures
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali.
M. M. Mesulam, MD, FAAN	No disclosure on file
James B. Leverenz, MD, FAAN	Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Julie A. Schneider, MD, MS	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for apellis. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for National Hockey League. The institution of Dr. Schneider has received research support from NIH. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a scientific advisor with Fondation Alzheimer, France.
	No disclosure on file

��ɫ��

��ɫ��